Figures computed from official regulatory filings — .
Insufficient history for a statistical track record (fewer than 5 open-market buys).
This page republishes public regulatory disclosures.
| Company | Type | Value · USD | Signals | Details | |
|---|---|---|---|---|---|
Panbela Therapeutics, Inc.Listing on record | BuyD (derivative) | n/a (Converted to USD in the nightly refresh) | First in 12mo | SEC | |
ImmunityBio, Inc.Listing on record | OtherD (derivative) | n/a (Converted to USD in the nightly refresh) | SEC | ||
ImmunityBio, Inc.Listing on record | OtherD (derivative) | n/a (Converted to USD in the nightly refresh) | SEC | ||
ImmunityBio, Inc.Listing on record | OtherD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC | ||
ImmunityBio, Inc.Listing on record | OtherD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC | ||
ImmunityBio, Inc.Listing on record | OtherD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC | ||
ImmunityBio, Inc.Listing on record | OtherD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC | ||
ImmunityBio, Inc.Listing on record | OtherD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC | ||
ImmunityBio, Inc.Listing on record | Other | $166.6M | SEC | ||
ImmunityBio, Inc.Listing on record | Other | $61.3M | SEC | ||
ImmunityBio, Inc.Listing on record | Other | $42.1M | SEC | ||
ImmunityBio, Inc.Listing on record | BuyD (derivative) | n/a (Converted to USD in the nightly refresh) | SEC | ||
Heliogen, Inc.Listing unverified | Buy | $1.8K | conv 45First in 12mo | SEC | |
Heliogen, Inc.Listing unverified | Award | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC | ||
Heliogen, Inc.Listing unverified | Award | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC | ||
NantHealth, Inc.Listing unverified | BuyD (derivative) | $3906.3T | First in 12mo | SEC |